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REPLY
We thank Drs. Nieto and Blumenthal for their thoughtful and
intriguing comments regarding our recent article (1). The major
findings in our study were that asymptomatic black subjects had a
lower prevalence of coronary calcium compared to white subjects,
but nevertheless suffered more coronary heart disease events during
a 70-month follow-up period. After adjusting for age, gender, and
coronary risk factors, black race was associated with an odds ratio
of 2.16 for a coronary event (95% CI limits, 1.34–3.48). Drs.
Nieto and Blumenthal advance two possible explanations of our
findings:
1. Blacks suffered higher rates of co-morbid conditions, risk
factors, and diminished access to health care treatment, collec-
tively impacting event-free survival deleteriously.
2. The duration from disease onset to event occurrence differed in
blacks compared to whites, secondary perhaps to a higher
case-fatality rate among our black subjects (incidence-
prevalence bias).
Drs. Nieto and Blumenthal suggest that our findings may at
least in part be explained by higher co-morbidities and risk factors
in blacks, combined with lower access to health care. This
possibility cannot be excluded, as we stated in our article. Blacks
underwent revascularization at rates similar to whites, yet it could
conceivably be argued that the rates of revascularization should
have in fact been higher in blacks, commensurate with their event
rate. Blacks in our study had roughly equivalent coronary risk
factors to whites; however, it is not at all clear that standard
coronary risk factors derived from epidemiologic investigations
comprised almost exclusively of white subjects are applicable to
blacks to the same extent that they are to whites. In fact, as we
pointed out, there is evidence that some risk factors such as
smoking, hypertension, and cholesterol have a different impact on
black subjects compared to white subjects. Although black and
white subjects in our study had equivalent overall Framingham
risk, black subjects had significantly higher systolic blood pressure
and body mass index and a higher incidence of diabetes mellitus
and a history of hypertension. Conversely, white subjects were
older, and they had a higher incidence of positive family history of
coronary heart disease. As we pointed out, it is possible that the
variable impact of standard risk factors on differing ethnic groups
could have affected our results.
Drs. Nieto and Blumenthal suggest that the inverse relation
between incidence (I) and disease duration (D) might explain the
lower prevalence of calcification and the higher incidence of
clinical events. If the proposed relation Prevalence 5 I 3 D were
valid, I could be higher for blacks even though Prevalence was
lower only if the disease duration, D, were much shorter for blacks.
However, this was not the case: the duration between screening
and events was the same for both ethnic groups (Table 1).
In addition, prevalence of calcification at the time of screening
is not the same as prevalence of clinical disease or even of
atherosclerosis. Calcification is only imperfectly related to athero-
sclerosis—and the latter only imperfectly related to clinical events.
Our findings regarding higher coronary event rates but lower
prevalence of calcium in blacks thus cannot be explained in the
manner proposed by Drs. Nieto and Blumenthal, and they pose
intriguing and important questions for further investigation.
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Table 1. Duration to Events in Black Subjects Compared to
White Subjects
Race
Mean Time (in Months)
to Event [SD] p*
Any Event*
White 46.7 [24.8] 0.52
Black 43.9 [26.2]
Myocardial Infarction
White 49.7 [26.8] 0.52
Black 56.6 [32.7]
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